Astex Pharmaceuticals

Astex Pharmaceuticals is a drug discovery and development company pioneering fragment-based drug discovery through its proprietary Pyramid platform, applied to oncology and central nervous system disorders.

Astex maintains an internal pipeline alongside active collaborations with MSD targeting KRAS and p53. The company integrates AI and machine learning and cryo-EM structural biology into its discovery platform.

Astex is a wholly owned subsidiary of Otsuka Pharmaceutical, co-founded in 1999 by University of Cambridge researchers.